Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiological Study of Glucose Metabolism Before and After Tacrolimus Withdrawal in Kidney Transplant Recipients
2010-022075-66Phase 4Terminated
- Sponsor
- Cardiff and Vale University Health Board
- Start
- Nov 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in Kidney allograft status (RTx), carbohydrate malabsorption and diabetes mellitus (DM), sponsored by Cardiff and Vale University Health Board. Primary endpoints: Change in pancreatic beta islet cell function and Change in insulin sensitivity. Started Nov 2010; status: terminated.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)carbohydrate malabsorptiondiabetes mellitus (DM)
Beyond the preview
Go deeper on 2010-022075-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022075-66.